• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Terazosin
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Hytrin
    Biotis
    RX
    partial basket chart
    Hytrin

    Selective α1 Blocker. Terazosin (as monohydrochloride dihydrate) 2 mg.
    TABS: Starter Pack: 7 x 1 mg, 2 mg. 28 x 5 mg, 10 mg. Initial: 1 x 1 mg tab 1 x
    dly at bedt. Incr. step-wise to 2 mg, 5 mg
    or 10 mg 1 x dly to achieve desired
    effect.
    Sympt. tmt. urinary obstruct. caused by
    BPH, mild to mod. hypertens.

    Terazosin Teva
    Teva
    RX
    not in the basket chart
    Terazosin Teva

    Selective α1 Blocker. Terazosin HCl dihydrate 5 mg.
    TABS: 30 x 5 mg. If discont. for
    several days, tmt. should be reinstitut.
    start. initial dos. regimen. BPH: Initial:
    1 mg at bedt., not to be exceed.
    Monitor during initial admin., risk of
    severe hypotens. Incr. stepwise to 2
    mg, 5 mg or 10 mg 1 x dly. 10 mg 1 x
    dly gen. req. for clin. response. Cont.
    for min. 4-6 wks. to assess benefic.
    response. Caution dur. concom. admin.
    other antihypertens., espec. verapamil,
    to avoid hypotens. Dose reduct./
    retitrat. may be necess. Hypertens:
    Adjust dose (12/24 hrs) acc. pts. BP
    response. Initial: 1 mg at bedt., not to
    be exceed. Monitor during initial
    admin., risk of severe hypotens. May
    be slowly incr., 1 mg-5 mg 1 x dly,
    some pts. 20 mg/day. Monitor BP at
    end of dos. interval; also 2-3 hrs. after
    dosing for excessive hypotens.
    response. If response is diminished at
    24 hrs, consider incr. dose or 2 x dly
    reg. Except initial dose, admin. in
    morning.
    Symptomat. tmt. urinary obstruct.,
    caused by BPH. Mild-mod. hypertens.
    C/I: Known hypersens.

    CLOSE